Adeshwar Meditex Ltd. engages in the manufacture of surgical dressings and external preparations products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-06-28. The firm offers its product across various categories, which include sterile wound dressings; combine dressing; gauze dressing and cotton products; medical bandages and plaster; antiseptics / disinfectants, and other products. Its sterile wound dressings products include Bactigauze, Petronet, Bactigauze Plus, Nitroheal, Pividine Povitulle and Polybane. Its combine dressing products include Combidress and Eye Pad. Its gauze dressing and cotton products include Absorbent Cotton Wool, Gauze Swab and Rolled Cotton Bandages. Its medical bandages and plaster products include Capsicum Belladonna Perforated Plaster and Plaster of Paris Bandage - A + Mediset. Its antiseptics / disinfectants include Biodex-C and Lysol I.P. Its other products include examination gloves and medical kits.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.